A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of SHR-2173 in Patients With Systemic Lupus Erythematosus
Clinical trial NCT06955598 · COMPLETED
Trial details
- NCT number
- NCT06955598
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-24
- Primary completion
- 2025-11-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.